Patient safety will always be the top priority of every clinical trial. Therefore, it is vital that the investigational medicine dispensed to the patient is pure, safe and effective, no matter what challenges are presented by packaging, storage and distribution requirements. In the next lines, Brian Keesee at PCI explains how the industry is adapting better solutions to effectively handle these challenging products.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/07/Innovations-in-cold-chain-technology.pdf” width=”100%” height=”900px” style=”border:0;”]